Literature DB >> 9928909

Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity.

T Kato1, J Murashita, A Kamiya, T Shioiri, N Kato, T Inubushi.   

Abstract

The authors have previously reported decreased intracellular pH (pHi) in the frontal lobes in euthymic bipolar patients treated with lithium using 31P-MRS. White matter hyperintensity (WMHI) is frequently seen in bipolar disorder. To examine a possible effect of lithium on pHi and the relationship between pHi and WMHI, seven drug-free euthymic bipolar patients were examined, and T2-weighted MRI were examined in 14 previously reported bipolar patients. Drug-free patients showed significantly lower pHi than controls. WMHI was associated with low pHi and increased phosphodiester peak. These results suggest that decrease of pHi is not an effect of lithium but is instead related to the pathophysiology of illness. Decrease of pHi and increase of the PDE peak may be the biochemical basis of WMHI in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9928909     DOI: 10.1007/s004060050054

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  27 in total

1.  Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Paul J Carlson; Young-Hoon Sung; Kristen K Fiedler; Lauren N Forrest; Tracy L Hellem; Rebekah S Huber; Seong-Eun Kim; Chun Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Bipolar Disord       Date:  2015-10-19       Impact factor: 6.744

2.  Alterations of the cerebellum and basal ganglia in bipolar disorder mood states detected by quantitative T1ρ mapping.

Authors:  Casey P Johnson; Gary E Christensen; Jess G Fiedorowicz; Merry Mani; Joseph J Shaffer; Vincent A Magnotta; John A Wemmie
Journal:  Bipolar Disord       Date:  2018-01-07       Impact factor: 6.744

Review 3.  Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.

Authors:  Stephen R Dager; Neva M Corrigan; Todd L Richards; Stefan Posse
Journal:  Top Magn Reson Imaging       Date:  2008-04

4.  Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder.

Authors:  C Yuksel; F Du; C Ravichandran; J R Goldbach; T Thida; P Lin; B Dora; J Gelda; L O'Connor; S Sehovic; S Gruber; D Ongur; B M Cohen
Journal:  Mol Psychiatry       Date:  2015-03-10       Impact factor: 15.992

Review 5.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Abnormalities in High-Energy Phosphate Metabolism in First-Episode Bipolar Disorder Measured Using 31P-Magnetic Resonance Spectroscopy.

Authors:  Fei Du; Cagri Yuksel; Virginie-Anne Chouinard; Polly Huynh; Kyle Ryan; Bruce M Cohen; Dost Öngür
Journal:  Biol Psychiatry       Date:  2017-04-07       Impact factor: 13.382

Review 7.  Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis.

Authors:  Christine Konradi; Stephanie E Sillivan; Hayley B Clay
Journal:  Neurobiol Dis       Date:  2011-02-17       Impact factor: 5.996

Review 8.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.

Authors:  Hayley B Clay; Stephanie Sillivan; Christine Konradi
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

Review 9.  A role for white matter abnormalities in the pathophysiology of bipolar disorder.

Authors:  Katie Mahon; Katherine E Burdick; Philip R Szeszko
Journal:  Neurosci Biobehav Rev       Date:  2009-11-06       Impact factor: 8.989

10.  Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo-inositol depletion.

Authors:  Dan Song; Ting Du; Baoman Li; Liping Cai; Li Gu; Hongmei Li; Ye Chen; Leif Hertz; Liang Peng
Journal:  Psychopharmacology (Berl)       Date:  2008-05-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.